Clinician Resource Library: Partnered CME Offerings
- Relapsed/Refractory CLL / SLL: Can You Apply Recent Evidence and Guidelines to These Challenging Cases? (MedScape: CME credit expires 5/16/25)
- Navigating Treatment Selection in CLL / SLL: Approaches for Initial and Refractory Cases (Paradigm: CME credit expires 4/15/2026)
- Point-Counterpoint: Deep Dive into CLL / SLL: Management of Newly Diagnosed and Refractory Disease (Paradigm: CME credit expires 5/8/2026)
- From Challenges to Changes in R/R CLL: Forging an Academic-Community Practice Alliance for Effective and Safe Sequential Care (PeerView: CME credit expires on 3/10/2026)
- The Challenges of Treating CLL / SLL: Optimizing Strategies for Patients With Initial and Refractory Disease (Paradigm Medical Communications: CME credit expires 1/31/2026)
- Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-Based Platforms (PeerView: CME credit expires 1/5/2026)
- Complex Cases in the Community Clinic: Managing Diverse Hematologic Malignancies (MedScape: CME credit expires 12/24/2025
- Building Resilient Care Communities for R/R CLL: Collaborative Sequential Approaches in an Era of Innovative Options (PeerView: CME credit expires 11/23/2025)
- Picking Paths in CLL: Individualizing Treatment Across the Disease Spectrum (Clinical Care Options Series: CME credit expires 4/1/25)
- From Resistance to Resilience in R/R CLL: Sequencing Strategies for Achieving Effective Continuous Care (PeerView: CME credit expires 2/16/25)
- Toward a Brighter Future for Preventing COVID-19 in Patients with Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation Agents (PeerView: CME credit expires 12/31/24)
- Therapy Selection in CLL: Knowing How to Choose in Frontline and R/R Settings (PleXus Communications: CME credit expires 11/16/24)
- Taking Direction from Biomarkers and Prognostic Factors in CLL: Interprofessional Strategies for Addressing Challenges with Continuous BTKi Therapy (PeerView: CME credit expires 8/1/24)
- Defying the Odds with Innovation in CLL: Perspectives on Personalized Care, Multiagent Platforms, and Sequential Strategies (PeerView: CME credit expires 7/2/24)
- Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics (PeerView: CME credit expires 5/26/24)
- Controlling and Conquering CLL: Guidance on Modern Targeted Options, Innovative Combinations, and Sequential Management (PeerView: CME credit expires 3/31/24)
